Nikko Asset Management Americas’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$15.8M	Buy	1,389,274 +633,304	+84%	+$7.2M	0.16%	78
2025 Q1	$8.98M	Sell	755,970 -33,252	-4%	-$395K	0.12%	86
2024 Q4	$14.9M	Buy	789,222 +236,620	+43%	+$4.46M	0.16%	78
2024 Q3	$12.4M	Buy	+552,602	New	+$12.4M	0.14%	82